Human medicines European public assessment report (EPAR): Cimzia, certolizumab pegol, Date of authorisation: 01/10/2009, Revision: 35, Status: Authorised

Human medicines European public assessment report (EPAR): Cimzia, certolizumab pegol, Date of authorisation: 01/10/2009, Revision: 35, Status: Authorised

Ninth Industry Standing Group (ISG) meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 28 June 2024, 09:00 (CEST) to 28 June 2024, 13:25 (CEST)

Ninth Industry Standing Group (ISG) meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 28 June 2024, 09:00 (CEST) to 28 June 2024, 13:25 (CEST)

Human medicines European public assessment report (EPAR): Raxone, idebenone, Date of authorisation: 08/09/2015, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Raxone, idebenone, Date of authorisation: 08/09/2015, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Rilutek, riluzole, Date of authorisation: 10/06/1996, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR): Rilutek, riluzole, Date of authorisation: 10/06/1996, Revision: 34, Status: Authorised

Twelfth meeting of the industry stakeholder platform on research and development support, European Medicines Agency, Amsterdam, the Netherlands, 4 July 2024

Twelfth meeting of the industry stakeholder platform on research and development support, European Medicines Agency, Amsterdam, the Netherlands, 4 July 2024

Human medicines European public assessment report (EPAR): Oprymea, pramipexole, Date of authorisation: 12/09/2008, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR): Oprymea, pramipexole, Date of authorisation: 12/09/2008, Revision: 25, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness